Tarsus Pharmaceuticals, Inc. (TARS)
68.24
-1.55
(-2.22%)
USD |
NASDAQ |
Mar 18, 16:00
68.19
-0.05
(-0.07%)
After-Hours: 05:37
Tarsus Pharmaceuticals Shareholders Equity (Quarterly) : 343.43M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Mirum Pharmaceuticals, Inc. | 314.69M |
| Summit Therapeutics, Inc. | 658.86M |
| Stoke Therapeutics, Inc. | 352.46M |
| Vir Biotechnology, Inc. | 765.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 566.90M |
| Total Liabilities (Quarterly) | 223.47M |
| Debt to Equity Ratio | 0.2418 |
| Current Ratio | 3.853 |
| Net Debt Paydown Yield | -0.06% |